Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label is updated to v3.5.4, indicating a minor update to the document version.
    Difference
    0.1%
    Check dated 2026-05-15T06:54:59.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer revision/version was updated from **v3.5.2** to **v3.5.3**, indicating a site release rather than a change to the clinical trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:23.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.2; the previous revision was v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:13:06.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:08:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:52:50.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added Tuberculosis as an item. Introduced a new resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-02-18T16:31:38.000Z thumbnail image

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.